Loading stock data…
$3.92-0.14 (-3.57%)
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.
Outset Medical, Inc. in the Healthcare sector is trading at $3.92 with a market capitalization of $59M. Wall Street consensus targets $7.67 (3 analysts), implying a +95.8% move over the next 12 months. The stock is currently near its 52-week low of $2.84, remaining 6.1% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 71 is overbought against a weak tape. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $31.64M↑ | $27.86M↓ | $28.87M↓ | $29.43M↓ | $31.42M |
| Gross Profit | $13.28M↑ | $12.10M↓ | $12.23M↑ | $11.59M↓ | $11.87M |
| Operating Income | -$15.68M↑ | -$16.92M↑ | -$17.63M↓ | -$15.81M↑ | -$16.86M |
| Net Income | -$17.98M↑ | -$18.98M↑ | -$19.49M↓ | -$17.84M↑ | -$18.54M |
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-de...